DeltaGold® Tocotrienol 70%: Clinical Trials

2 trials of DeltaGold® Tocotrienol 70%, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 withdrawn. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 1, Withdrawn 1
Phase 22Active not recruiting 1, Withdrawn 1

Follow DeltaGold® Tocotrienol 70%: new trials by email Literature Review of DeltaGold® Tocotrienol 70% trials Research Report on DeltaGold® Tocotrienol 70%

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tocotrienols for Skeletal Muscle Health
placebo softgel, DeltaGold® Tocotrienol 70% - Dynapenia, Postmenopausal Women
Phase 1 / Phase 2WithdrawnTexas Tech University Health Sciences Center2019-04-152022-02-18
Tocotrienols for Obesity of Postmenopausal Women
placebo softgel, DeltaGold® Tocotrienol 70% - Obesity, Postmenopausal Women
Phase 1 / Phase 2Active not recruitingTexas Tech University Health Sciences Center602019-03-152026-10-02

Conditions studied

Obesity (1)

Sponsors

Texas Tech University Health Sciences Center (2)

Countries

United States (2)

Top investigators

Chwan-Li Shen, PhD (2)

Results publications

PMID 32152169